Back to Companies
ALNYLAM PHARMACEUTICALS, INC.
ALNYNasdaqCIK: 0001178670
Recent Form 4 activity at ALNYLAM PHARMACEUTICALS, INC. (ALNY) spans 50 filings across 16 insiders (all of them on the sell side). Purchases total $0 against $83.7M in sales — heavily weighted toward selling, for net sales of $83.7M. Greenstreet Yvonne (Chief Executive Officer, Director) is the most active by dollar volume, and the single largest transaction was $22.0M by Ausiello Dennis A. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$136.7M
Purchases
$0
Sales
$83.7M
Unique Insiders
16
Recent Insider Trades
50 loaded
| Jun 3 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Cravatt Benjamin | Director | Other | $0 |
| Jun 3 | ALNY ALNYLAM PHARMACEUTICALS, INC. | PYOTT DAVID E I | Director | Sell | $1.1M |
| Jun 3 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Cravatt Benjamin | Director | Award | $1.3M |
| May 22 | ALNY ALNYLAM PHARMACEUTICALS, INC. | HAMBURG MARGARET A | Director | Grant | $430.1K |
| May 22 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Arbuckle Stuart A | Director | Grant | $430.1K |
| May 22 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sigal Charles Elliott | Director | Grant | $430.1K |
| May 22 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Reitan Colleen F | Director | Grant | $430.1K |
| May 14 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SCHULMAN AMY W | Director | Exercise | $1.6M |
| Apr 7 | ALNY ALNYLAM PHARMACEUTICALS, INC. | McLaughlin Melissa | Chief Human Resources Officer | Sell | $1.3M |
| Apr 7 | ALNY ALNYLAM PHARMACEUTICALS, INC. | McLaughlin Melissa | Chief Human Resources Officer | Other | $0 |
| Mar 6 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | Sell | $417.7K |
| Mar 4 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | Sell | $1.1M |
| Mar 4 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | EVP Chief R&D | Sell | $1.1M |
| Mar 4 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | Chief Executive Officer, Director | Sell | $2.2M |
| Mar 4 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Officer | Sell | $523.6K |
| Mar 4 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Poulton Jeffrey V. | EVP, Chief Financial Officer | Sell | $722.8K |
| Mar 4 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SUPRAN BRYAN | EVP, CLO and Secretary | Grant | $1.1M |
| Mar 2 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Poulton Jeffrey V. | EVP, Chief Financial Officer | Exercise | $0 |
| Mar 2 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | Chief Executive Officer, Director | Exercise | $0 |
| Feb 17 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | Sell | $1.3M |
| Feb 17 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Poulton Jeffrey V. | EVP, Chief Financial Officer | Sell | $695.2K |
| Feb 17 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Officer | Sell | $607.4K |
| Feb 17 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | Chief Executive Officer, Director | Sell | $2.2M |
| Feb 17 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | EVP Chief R&D | Sell | $695.2K |
| Jan 14 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Officer | Sell | $547.9K |
| Jan 14 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | Chief Executive Officer, Director | Sell | $3.5M |
| Jan 14 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | Sell | $1.4M |
| Jan 14 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Poulton Jeffrey V. | EVP, Chief Financial Officer | Sell | $1.0M |
| Jan 14 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | EVP Chief R&D | Sell | $547.9K |
| Jan 7 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Arbuckle Stuart A | Director | Award | $1.3M |
| Jan 7 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Arbuckle Stuart A | Director | Other | $0 |
| Dec 1 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | Chief Executive Officer, Director | Exercise | $1.5M |
| Nov 19 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | Sell | $5.5M |
| Nov 14 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | Chief Executive Officer, Director | Sell | $11.6M |
| Oct 3 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | EVP Chief R&D | Sell | $2.7M |
| Oct 3 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SUPRAN BRYAN | EVP, CLO and Secretary | Grant | $0 |
| Oct 3 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | Chief Executive Officer, Director | Sell | $4.0M |
| Oct 3 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Poulton Jeffrey V. | EVP, Chief Financial Officer | Sell | $1.7M |
| Oct 3 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | Sell | $1.1M |
| Oct 3 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Officer | Sell | $635.1K |
| Sep 22 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SUPRAN BRYAN | EVP, CLO and Secretary | Other | $0 |
| Sep 11 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Reitan Colleen F | Director | Sell | $8.4M |
| Sep 2 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Officer | Sell | $1.6M |
| Aug 19 | ALNY ALNYLAM PHARMACEUTICALS, INC. | BONNEY MICHAEL W | Director | Sell | $5.1M |
| Aug 19 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Poulton Jeffrey V. | EVP, Chief Financial Officer | Sell | $1.0M |
| Aug 19 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Garg Pushkal | EVP Chief R&D | Sell | $1.3M |
| Aug 19 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | Sell | $632.8K |
| Aug 19 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Tanguler Tolga | EVP, Chief Commercial Officer | Sell | $632.8K |
| Aug 19 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Greenstreet Yvonne | Chief Executive Officer, Director | Sell | $3.2M |
| Aug 15 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Ausiello Dennis A | Director | Sell | $13.7M |
50 filings